Clinical trial
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to…
NCT00118508 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00118508 |
|---|---|
| Title | The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study) |
| Official title | The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study) |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | Procter and Gamble Industry Aventis Pharmaceuticals |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | risedronate (including placebo) |
| Enrollment | 87 |
| Start date | May 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jul 11, 2005 |
| Last update posted | Aug 13, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: